InspireMD EPS - Earnings per Share 2013-2025 | NSPR
InspireMD eps - earnings per share from 2013 to 2025. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| InspireMD Annual EPS | |
|---|---|
| 2024 | $-0.76 |
| 2023 | $-0.82 |
| 2022 | $-2.35 |
| 2021 | $-2.03 |
| 2020 | $-6.97 |
| 2019 | $-71.96 |
| 2018 | $-249.93 |
| 2017 | $-26,221.89 |
| 2016 | $-155,712.20 |
| 2015 | $-1,463,866.00 |
| 2014 | $-7.09 |
| 2013 | $0.00 |
| 2013 | $-1.39 |
| 2012 | $0.00 |
| 2012 | $-1.04 |
| 2011 | $0.00 |
| InspireMD Quarterly EPS | |
|---|---|
| 2025-03-31 | $-0.22 |
| 2024-12-31 | $-0.17 |
| 2024-09-30 | $-0.16 |
| 2024-06-30 | $-0.22 |
| 2024-03-31 | $-0.21 |
| 2023-12-31 | $0.10 |
| 2023-09-30 | $-0.15 |
| 2023-06-30 | $-0.24 |
| 2023-03-31 | $-0.53 |
| 2022-12-31 | $-0.61 |
| 2022-09-30 | $-0.58 |
| 2022-06-30 | $-0.59 |
| 2022-03-31 | $-0.57 |
| 2021-12-31 | $-0.51 |
| 2021-09-30 | $-0.53 |
| 2021-06-30 | $-0.46 |
| 2021-03-31 | $-0.53 |
| 2020-12-31 | $3.34 |
| 2020-09-30 | $-0.96 |
| 2020-06-30 | $-2.93 |
| 2020-03-31 | $-6.42 |
| 2019-12-31 | $28.04 |
| 2019-09-30 | $-18.89 |
| 2019-06-30 | $-23.84 |
| 2019-03-31 | $-57.27 |
| 2018-12-31 | $711.54 |
| 2018-09-30 | $-37.03 |
| 2018-06-30 | $-114.84 |
| 2018-03-31 | $-809.60 |
| 2017-12-31 | $5,389.81 |
| 2017-09-30 | $-4,917.54 |
| 2017-06-30 | $-5,472.26 |
| 2017-03-31 | $-21,221.89 |
| 2016-12-31 | $169,562.30 |
| 2016-09-30 | $-22,279.07 |
| 2016-06-30 | $-119,520.70 |
| 2016-03-31 | $-183,474.70 |
| 2015-12-31 | $-1,151,171.00 |
| 2015-09-30 | $-312,693.30 |
| 2015-06-30 | $-0.51 |
| 2015-03-31 | $-1.04 |
| 2014-12-31 | $-4.73 |
| 2014-09-30 | $-1.96 |
| 2014-06-30 | $-0.22 |
| 2014-03-31 | $-0.18 |
| 2013-12-31 | $0.00 |
| 2013-09-30 | $-0.12 |
| 2013-06-30 | $-0.48 |
| 2013-03-31 | $-0.27 |
| 2012-12-31 | $0.00 |
| 2012-09-30 | $-0.44 |
| 2012-06-30 | $0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.078B | $0.007B |
| InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous vein graft coronary interventions. It focuses on applying its technology to develop additional products used for other vascular procedures, specifically carotid and peripheral procedures. InspireMD Inc. is headquartered in Tel Aviv, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $193.381B | 84.70 |
| Thermo Fisher Scientific (TMO) | United States | $148.604B | 17.98 |
| Edwards Lifesciences (EW) | United States | $43.989B | 28.84 |
| Alcon (ALC) | Switzerland | $42.676B | 28.84 |
| IDEXX Laboratories (IDXX) | United States | $40.337B | 46.36 |
| DexCom (DXCM) | United States | $33.137B | 51.22 |
| STERIS (STE) | Ireland | $23.875B | 26.33 |
| IQVIA Holdings (IQV) | United States | $23.701B | 13.27 |
| Mettler-Toledo (MTD) | United States | $23.155B | 27.54 |
| Waters (WAT) | United States | $20.612B | 29.08 |
| SONOVA HOLDING (SONVY) | Switzerland | $19.146B | 0.00 |
| Hologic (HOLX) | United States | $12.096B | 13.14 |
| Sysmex ADR (SSMXY) | Japan | $10.632B | 30.16 |
| Penumbra (PEN) | United States | $10.399B | 81.62 |
| Masimo (MASI) | United States | $8.140B | 30.03 |
| Globus Medical (GMED) | United States | $7.982B | 19.02 |
| Glaukos (GKOS) | United States | $5.487B | 0.00 |
| Teleflex (TFX) | United States | $5.337B | 8.81 |
| TransMedics (TMDX) | United States | $4.203B | 91.36 |
| Integer Holdings (ITGR) | United States | $4.128B | 21.63 |
| PROCEPT BioRobotics (PRCT) | United States | $3.175B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.284B | 13.60 |
| Veracyte (VCYT) | United States | $2.127B | 29.85 |
| Nihon Kohden (NHNKY) | Japan | $1.943B | 22.28 |
| Elekta AB (EKTAY) | Sweden | $1.922B | 17.28 |
| Alphatec Holdings (ATEC) | United States | $1.820B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.380B | 0.00 |
| Artivion (AORT) | United States | $1.222B | 114.44 |
| Pulse Biosciences (PLSE) | United States | $1.136B | 0.00 |
| OPKO Health (OPK) | United States | $0.999B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.956B | 5.08 |
| SiBone (SIBN) | United States | $0.783B | 0.00 |
| IRadimed (IRMD) | United States | $0.650B | 32.96 |
| RxSight (RXST) | United States | $0.637B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.626B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.597B | 13.05 |
| NeuroPace (NPCE) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.569B | 8.86 |
| Delcath Systems (DCTH) | United States | $0.561B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.506B | 0.00 |
| AxoGen (AXGN) | United States | $0.504B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.494B | 13.15 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.435B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.384B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.370B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.333B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.263B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.219B | 13.27 |
| Alpha Tau Medical (DRTS) | Israel | $0.211B | 0.00 |
| Inogen (INGN) | United States | $0.176B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.175B | 0.00 |
| CVRx (CVRX) | United States | $0.174B | 0.00 |
| 908 Devices (MASS) | United States | $0.172B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.172B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.165B | 0.00 |
| Accuray (ARAY) | United States | $0.162B | 0.00 |
| LENSAR (LNSR) | United States | $0.160B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.144B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.143B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.131B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.107B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.097B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.093B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.077B | 46.90 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.059B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.055B | 16.67 |
| Hyperfine (HYPR) | United States | $0.042B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Spectral AI (MDAI) | United States | $0.037B | 0.00 |
| Envoy Medical (COCH) | United States | $0.035B | 0.00 |
| Precision Optics (POCI) | United States | $0.033B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.032B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.008B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.58 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |